For every four adults in the world who are malnourished five more are overweight, 30 percent of them clinically obese, according to the World Health Organization.

At a time when another TZD, rosiglitizone is showing promise in preventing diabetes, this new review calls into the question the health benefits versus risks of Actos, an oral medicine widely prescribed for diabetes throughout the United States, Canada, Europe and Asia.

Drinking 6 ounces of pomegranate juice daily may protect diabetics from developing heart disease, according to a new study.

According to the results of a new study, DHEA, a widely used antiaging supplement has no effect on aging markers such as muscle strength, peak endurance, muscle mass, fat mass and glucose tolerance in elderly men and women.

WHITEHOUSE STATION, N.J., Oct. 17, 2006 — Merck & Co., Inc. announced today that the U.S. Food and Drug Administration (FDA) approved JANUVIA™ (sitagliptin phosphate), the first and only DPP-4 inhibitor available in the United States for the treatment of type 2 diabetes. JANUVIA has been approved as monotherapy and …

October 2006 – Middle-aged adults with a high body mass index (BMI) received lower scores on cognitive tests than middle-aged adults with low BMI, according to a study published in the October 10, 2006, issue of Neurology, the scientific journal of the American Academy of Neurology.

September 2006 – New UK research indicates that taking beta-blocker drugs to treat high blood pressure can increase the risk of developing diabetes by 50 percent, compared to newer drugs.

The FDA announced today the approval of Januvia (sitagliptin phosphate) Tablets, the first diabetes treatment approved in a new class of drugs known as DDP-4 inhibitors that enhances the body’s own ability to lower elevated blood sugar.

Results indicate an increased risk of vitamin B12 deficiency associated with current dose and duration of metformin.

New system provides more options for insulin pump users.